GSE153443 decitabine 1 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE153443_decitabine_1_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE153443_decitabine_1_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE153443_decitabine_1_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE153443_decitabine_1_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H2A clustered histone 19

Gene

cutA divalent cation tolerance like, pseudogene

Gene

zinc finger protein 883

Gene

zinc finger protein 271, pseudogene

Gene

zinc finger protein 826, pseudogene

Gene

ANKRD13C divergent transcript

Gene

uncharacterized LOC102724843

Gene

butyrophilin like 12, pseudogene

Gene

TRAM2 antisense RNA 1

Gene

GBX2 and ASB18 antisense RNA 1

  • Gene

    H2A clustered histone 19


  • Gene

    cutA divalent cation tolerance like, pseudogene


  • Gene

    zinc finger protein 883


  • Gene

    zinc finger protein 271, pseudogene


  • Gene

    zinc finger protein 826, pseudogene


  • Gene

    ANKRD13C divergent transcript


  • Gene

    uncharacterized LOC102724843


  • Gene

    butyrophilin like 12, pseudogene


  • Gene

    TRAM2 antisense RNA 1


  • Gene

    GBX2 and ASB18 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.